Candel Therapeutics, Inc. (CADL) NASDAQ
7.04
-0.3(-4.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 299.22M |
| Enterprise Value | 181.39M |
| P/E Ratio | -10.54 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.75 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -6.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.3 |
| Return On Equity | -0.51 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -845,000 |
| EBITDA | -47.42M |
| Net Income | -38.18M |
| Diluted EPS | -0.72 |
Balance Sheet
| Total Cash | 119.73M |
| Total Cash/Share | 2.18 |
| Total Debt | 1.9M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 13.31 |
| Book Value Per Share | 0.95 |
Price History
| 52-Week Change | 54.08 |
| 52-Week High | 7.66 |
| 52-Week Low | 4.34 |
| Moving Average 50 Days | 5.24 |
| Moving Average 200 Days | 5.54 |
Statistics
| Average Volume | 1.36M |
| Shares Outstanding | 54.9M |
| % Held by Institutions | 43.05 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
